NCT00150657View on ClinicalTrials.gov

Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer

PHASE2UnknownINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

November 30, 2004

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG

bevacizumab

DRUG

carboplatin

DRUG

gemcitabine

Trial Locations (1)

48075

RECRUITING

Providence Cancer Institute, Southfield

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

lead

St. John Providence Health System

OTHER